Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment-Reference-Cited by-同舟云学术

Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment

Published:2017-08-27 Issue:12 Volume:83 Page:2678-2686
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Kropeit Dirk¹^ORCID,McCormick David²,Erb‐Zohar Katharina³,Moiseev Valentin S.⁴,Kobalava Zhanna D.⁵,Stobernack Hans‐Peter¹,Zimmermann Holger¹,Rübsamen‐Schaeff Helga¹

Affiliation:

1. AiCuris Anti‐infective Cures GmbH Wuppertal Germany

2. DMPK Solutions Limited Nottingham UK

3. Clinphase Hanau Germany

4. Centre for Applied Clinical Pharmacology, Clinical Hospital #3GOUVPO Russian Peoples' Friendship University Moscow Russia

5. Centre for Applied Clinical Pharmacology, City Clinical Hospital #64GOUVPO Russian Peoples' Friendship University Moscow Russia

Funder

Aicuris Anti-infective Cures GmbH

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13376

Reference17 articles.

1. Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment

2. Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

3. Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus;Melendez DP;Infect Drug Resist,2015

4. Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection

5. Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome;Salzberger B;Blood,1997

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation;Clinical Pharmacokinetics;2024-07

2. Antiviral Agents: Letermovir;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

3. Naturally Occurring Herbs and their Bioactive Metabolites: Potential Targets and Signaling Pathways of Antiviral Agents;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-10

4. Burgeoning therapeutic strategies to curb the contemporary surging viral infections;Microbial Pathogenesis;2023-06

5. Lactic acidosis after allogeneic haematopoietic stem cell transplantation potentially related to letermovir;British Journal of Clinical Pharmacology;2023-02-19